Community Academic Profiles

Randall Stafford

Understanding Pine Bark Extract as an Alternative Treatment (UPBEAT) Study

Contact Information

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Primary Contact:

Rebbeca Drieling (650) 723-6528
To view all clinical trials at Stanford, please see the Clinical Trials Directory.

Brief

The purpose of this study is to investigate the efficacy of Flavangenol? (Toyo Shinyaku, Japan), a pine bark extract, in lowering blood pressure and improving glycemic control and plasma lipoprotein profile.

Recruiting Status:

Completed

Stanford Recruiting Status:

Completed

Condition(s):

Intervention(s):

  • Drug: Pine Bark Extract (Flavangenol?)

Phase:

N/A

Eligibility

Ages Eligible for Study:

18 years to Any Age

Genders Eligible for Study:

Male and Female

Health of Volunteers:

People with the conditions listed in this trial can not participate as controls.

Key Inclusion Criteria:

:-Systolic blood pressure between 125 and 159 mmHg and diastolic blood pressure (DBP) < 100 mmHg
-Body mass index (BMI) 25.0-34.9
-Triglycerides (TG) < 450 mg/dL
-Low Density Lipoprotein (LDL) < 200 mg/dL
-Fasting blood glucose (FBG) < 126 mg/dL

Key Exclusion Criteria:

-DBP > 95 mmHg
-LDL > 170 mg/dL
-TG > 300 mg/dL
-FBG > 110 mg/dL

Additional Study Details

Official Title:

Cardiovascular Effects of Pine Bark Extract

Anticipated start date:

10/1/2006

Lead Sponsor:

Stanford University

Study Type:

Interventional

Purpose:

Prevention

Allocation:

Randomized

Masking:

Double Blind

Control:

none

Assignment:

Parallel

Endpoints:

Safety/Efficacy

Primary Outcomes:

  • Blood pressure (primary outcome)

Secondary Outcomes:

  • Weight and height
  • Waist circumference
  • Fasting blood glucose
  • Hemoglobin A1c
  • Fasting insulin
  • Lipid panel w/ calculated LDL
  • LDL particle subclass analysis
  • Lipoprotein A
  • C-reactive protein
  • ALT/SGPT
  • AST/SGOT
  • 3-day food record

Total Number to be Enrolled:

0

Total Number to be Enrolled at Stanford:

130

More Information

Trial Unique Id: 37698

Locations & Contacts

Stanford Locations & Contacts:

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Primary Contact:

Rebbeca Drieling (650) 723-6528

Non-Stanford Locations:

The Stanford website does not have any locations outside of Stanford listed for this trial. You may want to check clinicaltrials.gov for posible additional locations.

This listing was last updated:

2/13/2009

PLEASE NOTE:

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician. If you do not have a primary care physician please feel free to call the SHC Physician Referral Service at (800) 756-9000 or send an email.

Stanford Medicine Resources:

Footer Links: